bioAffinity Technologies vs BioCircuit Technologies

bioAffinity Technologies

Addressing a critical need to find cancer early and treat cancer at the cellular level

22 employees · est. 2014 · San Antonio, United States

BioCircuit Technologies

Precision made simple

30 employees · est. 2016 · Atlanta, United States

bioAffinity Technologies is the older company (2014 vs 2016).

Side-by-Side Comparison

Metric	bioAffinity Technologies	BioCircuit Technologies
Founded
Founded	2014 older	2016
Headquarters
Headquarters	San Antonio, United States	Atlanta, United States
Employees
Employees	22	30
Industry
Industry	Biotechnology, Health Care	Biotechnology, Health Care, Manufacturing
Funding Stage
Funding Stage	Post-IPO Equity	Grant
Total Funding
Total Funding	$27.25M	$14.60M
Funding Rounds
Funding Rounds	5	5
Taxonomy
Taxonomy	Cancer DiagnosisLung Cancer DetectionNoninvasive TestingPrecision MedicineCellular Level TreatmentEarly-stage Cancer Diagnosis +7	ElectrophysiologyNerve RepairTissue RepairNoninvasiveDiagnosis ToolsHealth Monitoring +2
Website
Website	bioaffinitytech.com	biocircuit.com

About bioAffinity Technologies

bioAffinity Technologies is a biotechnology company based in the United States, founded in 2014. The company focuses on addressing the critical need to detect and treat cancer at the cellular level, particularly targeting early-stage lung cancer and other lung diseases. Their flagship product, CyPat...

View Full Profile Alternatives

About BioCircuit Technologies

BioCircuit Technologies is a medical device company that focuses on the development of tools for the repair of nerve and other tissues. Founded in 2016, the company operates in the Biotechnology, Health Care, and Manufacturing industries with its headquarters in the United States. The company recent...

View Full Profile Alternatives

Also comparing in this category

Comparing more than these two?

Get bioAffinity Technologies, BioCircuit Technologies and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does bioAffinity Technologies compare?

A PDF of bioAffinity Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

bioAffinity Technologies was founded in 2014, based in San Antonio, United States, with 22 employees. bioAffinity Technologies is a biotechnology company based in the United States, founded in 2014. The company focuses on addressing the critical need to detect and treat cancer at the cellular level, p. BioCircuit Technologies was founded in 2016, based in Atlanta, United States, with 30 employees. BioCircuit Technologies is a medical device company that focuses on the development of tools for the repair of nerve and other tissues. Founded in 2016, the company operates in the Biotechnology, Heal.

bioAffinity Technologies has raised $27.25M and BioCircuit Technologies $14.60M. Latest stage: bioAffinity Technologies Post-IPO Equity, BioCircuit Technologies Grant.

Both work in Biotechnology and Health Care and list precision medicine among their focus areas.

Compare bioAffinity Technologies with someone else

Start typing a company name or domain.

Related Comparisons

bioAffinity Technologies vs Optellum bioAffinity Technologies Alternatives BioCircuit Technologies Alternatives All Companies All Signals

Compiled from the BounceWatch company index. We last looked at bioAffinity Technologies on 15 Sep 2024, and BioCircuit Technologies on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.